Roy Herbst, MD, PhD, of Yale Cancer Center, recently discussed groundbreaking new data surrounding osimertinib (Tagrisso) in patients with EGFR-mutated non-small cell lung cancer (NSCLC). The LAURA and ADAURA trials have provided exciting insights into the potential of osimertinib in improving progression-free survival for patients with stage III NSCLC. The findings from the ADAURA trial
Health
Systemic lupus erythematosus (SLE) is a complex autoimmune disease that can affect various organs in the body, including the kidneys. A recent analysis of medical records has suggested that patients with SLE who were taking metformin had lower rates of lupus nephritis, chronic kidney disease (CKD), and major adverse cardiovascular events (MACE) compared to those
Rheumatoid arthritis (RA) patients face an increased risk of major adverse cardiovascular events (MACE) and mortality. Standard risk factors do not fully account for these risks in RA patients, prompting researchers to investigate alternative measures such as high-sensitivity cardiac troponin T (hs-cTnT) testing. A recent study conducted at Brigham and Women’s Hospital in Boston revealed
A recent study sheds light on the missed opportunities in treating drug overdose survivors who are covered by the Medicare program. The study highlights the challenges in managing chronic pain and addiction, demonstrating a significant gap in the provision of holistic care for this vulnerable population. According to Brian Hurley, MD, president of the American
Recently, the FDA has approved two new immunotherapy-chemotherapy options for patients with primary advanced or recurrent endometrial cancer. One of these options is the PD-1-directed immune checkpoint inhibitor pembrolizumab, also known as Keytruda. This drug has been approved in combination with carboplatin and paclitaxel for patients with either mismatch repair (MMR)-deficient or MMR-proficient disease. The
In the field of medicine, it is crucial to critically analyze statements made by healthcare professionals to ensure accuracy and reliability. Misinterpretation or misunderstanding of medical information can have serious consequences for patients and the overall healthcare system. When examining quotes such as “The only side effects are good ones” by Dean Ornish, MD, it
In a recent randomized trial presented at the European Alliance of Associations for Rheumatology (EULAR) annual meeting, the feasibility of remote monitoring for patients with axial spondyloarthritis (axSpA) was explored. The study, conducted by Inger Jorid Berg, MD, PhD, of Diakonhjemmet Hospital in Oslo, Norway, aimed to compare the effectiveness of three different approaches to
Air pollution is not just an environmental concern, but a looming threat to human health, especially for expectant mothers. Recent studies have brought to light the concerning link between maternal exposure to particulate matter (PM) and adverse pregnancy outcomes, particularly in relation to blood pressure complications. As we navigate through a world grappling with pollution
The study conducted by Dr. Erminia Massarelli focused on evaluating the combination of osimertinib and consolidative stereotactic ablative radiation (SABR) for the treatment of advanced EGFR-mutant non-small cell lung cancer (NSCLC). This study was carried out in collaboration with UT Southwestern and included 43 untreated patients with metastatic and incurable disease. The results of the
A recent social media post shared the story of a woman who experienced hives all over her body after breastfeeding her newborn son. Upon visiting a doctor due to also developing a headache, she received a shocking diagnosis: lactation anaphylaxis, a rare condition where the individual is allergic to breastfeeding. This condition, as described by